Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life

Emanuela Lattuada, Massimiliano Lanzafame, Stefano Nicolè, Fabio Rigo, Giulia Cucchetto, Ercole Concia, Sandro Vento

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)206-207
Number of pages2
JournalInternational Journal of STD and AIDS
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 1 2018

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Lattuada, E., Lanzafame, M., Nicolè, S., Rigo, F., Cucchetto, G., Concia, E., & Vento, S. (2018). Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life. International Journal of STD and AIDS, 29(2), 206-207. https://doi.org/10.1177/0956462417747832